Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: WES and RNA sequencing of biopsies from a Phase I Trial
This dataset contains whole-exome and RNA sequencing of biopsies obtained from patients enrolled in a phase I clinical trial investigating the UV1 vaccine in combination with pembrolizumab in patients with advanced melanoma.
- 86 samples
- DAC: EGAC00001003302
- Technology: Illumina NovaSeq 6000
Data Access Agreement must be signed before any applicant can gain access to the dataset.
Access to the dataset is contingent on a signed Data Access Agreement between the applicant and Ultimovacs ASA
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
| Study ID | Study Title | Study Type |
|---|---|---|
| Other |